RESUMEN
OBJECTIVES: Patients undergoing myocardial revascularisation using extracorporeal circulation require heparin anticoagulation. We aimed to evaluate the effect of reducing heparin dosage on target activated clotting time (ACT) and postoperative blood loss. METHODS: In a prospective randomised trial, 195 patients undergoing isolated primary CABG were randomised into four groups A, B, C, and D receiving an initial heparin dosage of 100, 200, 250 and 300 iu/kg, respectively. Extra incremental heparin (50 iu/kg) was added if required to achieve a target ACT of 480 s before initiating cardiopulmonary bypass. Postoperative blood loss was measured from the time of heparin reversal to drain removal 24h later. RESULTS: Target ACT was achieved in 0, 63, 68.3 and 82.4% of patients in groups A, B, C and D, respectively, after the initial dose of heparin. In group B, of those not achieving target act a single increment of heparin was sufficient to achieve target ACT in further 18.6%. The mean ACT after the initial dose in groups B, C and D was 482.9, 519 and 588 s, respectively (P<0.05). Postoperative blood loss in millilitre per kilogram was directly proportional to preoperative heparin dose. CONCLUSIONS: Patients receiving lower dose of heparin has lower postoperative blood loss. Of those achieving the target ACT, group B was significantly the closest to the target ACT. A starting dose of 200 iu/kg of heparin and if necessary one 50 iu/kg increment achieved target ACT in 81.5% of patients. The added benefit of significant drop in postoperative blood loss is evident.
Asunto(s)
Anticoagulantes/administración & dosificación , Puente Cardiopulmonar , Heparina/administración & dosificación , Hemorragia Posoperatoria/inducido químicamente , Anciano , Anticoagulantes/efectos adversos , Coagulación Sanguínea/efectos de los fármacos , Puente de Arteria Coronaria , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Heparina/efectos adversos , Humanos , Cuidados Intraoperatorios/métodos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Tiempo de Coagulación de la Sangre TotalRESUMEN
A study was undertaken to determine the distribution, antibiotic susceptibility and phage type pattern of nasally-carried Staphylococcus aureus in the community. Coagulase-positive staphylococci were isolated from 180 of 440 individuals. The rate was higher in the inner city and among young adults and middle-aged males. The isolates were examined for phage-type patterns and antibiotic susceptibility. Most (60.6%) of the isolates were typable either at Routine Test Dilution (RTD) or at 100 RTD. Most belonged to phage group I (53.2%) and phage group III (21.1%). Susceptibility to penicillin and ampicillin was low at 12.3 and 15.5% respectively. All were susceptible to vancomycin. Methicillin-resistance was unexpectedly low at 0.6% whereas tetracycline and erythromycin resistance were in line with recent trends at 4.5 and 2.7%. The rate of multiple resistance was low at 2.3%.